Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation TVT 2023

Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Mazhed Kheyrbek

June 10, 2023

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

Presentation TVT 2022

Full-Body Embolic Protection With Debris Capture

Presenter: Ran Kornowski

June 10, 2022

Presentation TVT 2022

Cerebral Embolic Protection Through Deflection: Aortic-Arch Devices

Presenter: Rahul Prakash Sharma

June 10, 2022

Presentation TVT 2022

Cerebral Embolic Protection With Capture: Next Generation Sentinel

Presenter: Axel Linke

June 10, 2022

Presentation TVT 2022

Defining My Wish-List for the Ideal CEP Device

Presenter: Giora Weisz

June 10, 2022

Presentation TVT 2022

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

Presenter: Maheedhar Gedela

June 10, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Advertisement

Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Full-Body Embolic Protection With Debris Capture

Cerebral Embolic Protection Through Deflection: Aortic-Arch Devices

Cerebral Embolic Protection With Capture: Next Generation Sentinel

Defining My Wish-List for the Ideal CEP Device

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Status Updates on the Next Generation of Cerebral Protection Devices

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content